☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Stable
Seattle Genetics Report Updated Results of Tukysa (tucatinib) in HER2CLIMB Study for Patients with HER2-Positive Breast Cancer wit...
June 1, 2020
AstraZeneca's Lokelma Receives CHMP's Recommendation for Approval for Patients with Hyperkalemia on Stable Hemodialysis
March 31, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.